
Reach more patients. Enable support at scale.
Tucuvi helps pharmaceutical and medical device companies execute patient programs at scale, from early outreach and enrollment to structured follow-up, ongoing support and measurable outcomes.





.png)

Reach, engage and support patients.
Real programs. Different therapeutic objectives.


.png)

Different objectives. One platform to execute them.
Healthcare Partnership Programs
Support healthcare provider-led programs developed in collaboration with Life Sciences companies. LOLA® works within healthcare teams' defined workflows to reach eligible patients, collect relevant information and support interventions across prevention, treatment optimization and ongoing care.
- Expand Screening & Patient Outreach
- Accelerate Time to Treatment
- Optimize Treatment
.png)
Clinical Trials
Support clinical research teams with patient outreach, enrollment coordination and structured follow-up throughout the study. LOLA® helps collect patient-reported information, monitor participation and identify cases requiring attention, following predefined study protocols.
- Support Patient Recruitment & Enrollment
- Improve Participant Engagement & Retention
- Capture Structured Patient-Reported Data
.png)
Patient Support Programs
Support patients throughout medication and medical device programs, from initial onboarding to ongoing treatment and follow-up. LOLA® engages patients through accessible, structured conversations, helping them understand program steps, share treatment experiences, identify barriers to adherence and persistence, and connect with support teams when needed.
- Simplify Enrollment & Onboarding
- Improve Treatment Adherence
- Support Therapeutic Persistence
.png)
Wide range of therapeutic areas
Reach, engage and support patients, safely and at scale
Patient Identification, access & enrollment
Identify and reach eligible patient populations, supporting access to care, clinical trial enrollment and onboarding into treatment or device programs.
Patient Engagement & Continuity
Keep patients engaged throughout treatment, clinical research and long-term follow-up. Identify barriers, unmet needs and situations requiring professional support.
Measurable Program Impact
Capture aggregated patient-reported information and program data to measure participation, completion, treatment continuity and other program-specific outcomes.
Clinical Safety & Compliance
Run patient-facing programs as a CE-marked Class IIb medical device that meets globally recognized standards, within an approved scope, with human oversight, data protection and traceability built into every interaction.
Built for Life Sciences
Patient programs depend on staying in contact with each patient at the right moment. LOLA holds those conversations at scale and returns structured data to marketing, market access, medical affairs and clinical teams.

.png)
.
Turn program activity into information that supports better decisions.
Tucuvi Data gives Life Sciences partners aggregated program data through a secure dashboard portal. Each program’s KPIs are defined and validated before launch, combining clinical actions, patient responses and baseline data, so results can be followed over time, compared across projects and reported with confidence.
Defined Indicators
Establish what will be measured, how each KPI is defined and which data sources will be used.
Program Performance
Track patient reach, engagement, completed steps, incomplete activities and other agreed program metrics.
Anonimyzed Program Reports
Capture relevant symptoms, adverse events, PROs, PREMs and cases requiring professional follow-up, where included in the defined program.
Frequently Asked Questions
Tucuvi helps Life Sciences companies enable timely, scalable contact with patients across the entire care pathway through an AI Care Management Platform. Through structured, protocol-based conversations at each clinical stage, from identification and diagnosis to treatment initiation and long-term follow-up, Tucuvi helps healthcare teams reduce delays, prioritise patients who need attention and optimise the pathway at every level of care.
Patient Support Programs are one of the many ways Tucuvi collaborates with Life Sciences companies. Within these programs, Tucuvi supports onboarding, patient education, treatment follow-up, questionnaires, information requests and adherence-related workflows. Programs can be configured around specific patient needs and responsibilities, with appropriate healthcare professional oversight.
Patients often become non-adherent because they lack timely reminders, or simply because they feel well enough to believe they no longer need to take their medication as prescribed. This is why timely follow-up plays a key role in supporting adherence. Tucuvi helps identify symptoms, treatment barriers and unmet needs that may affect continuity. Patient-reported information is structured to support professional follow-up. Improvements in adherence or persistence must be demonstrated with program-specific data.
Tucuvi can support healthcare-led outreach and follow-up programs designed to help patients progress through treatment pathways. Eligibility and prescribing decisions remain with clinical teams. Commercial outcomes such as new patient starts require specific measurement.
Patient Support Programs focus on treatment-related needs such as onboarding and adherence. In these programs, LOLA® carries out structured follow-up from outside the hospital, so healthcare professionals do not have to perform these activities themselves. Healthcare partnerships support broader clinical objectives, including prevention, treatment optimization and longitudinal care. In these partnerships, LOLA®, Tucuvi's Clinical Voice AI, becomes part of the hospital's clinical team, and all calls are managed from within the clinical department itself. Tucuvi can support both through configurable workflows.
LOLA®, Tucuvi's Clinical Voice AI, enables natural telephone conversations across a wide range of program activities, including onboarding, questionnaires, identification of potentially underdiagnosed patients, symptom monitoring, adverse event follow-up, and support for medication adherence and treatment persistence, among others. All of this is managed through the simplest channel for patients, a phone call, which helps achieve high patient reach and engagement rates. Responses are structured within Tucuvi Health Manager to support program execution and identify cases requiring attention.
LOLA® is designed to act as a primary patient-facing data collection tool in clinical trials, covering critical points across the study, such as patient identification and enrollment (often a key cause of delays in study execution), disease monitoring, reminders, patient-reported outcomes, appointment scheduling, adverse event follow-up and safety surveillance. Tucuvi is also designed to integrate with the information systems typically involved in a clinical trial.
Tucuvi Health Manager supports indicators such as patient reach, engagement, completed follow-ups, reported symptoms and other program-defined outcomes. Each program operates within agreed clinical, data protection and regulatory responsibilities. LOLA® is a Software as a Medical Device (SaMD), CE-marked as a Class IIb medical device under the EU Medical Device Regulation (MDR). Tucuvi complies with GDPR, is certified under ISO 27001 for information security, and meets the requirements of Spain's National Security Framework (ENS). Data is hosted on Google Cloud Platform in EU regions.


.png)























